NEPHROTOXICITY OF GERMANIUM COMPOUNDS - REPORT OF A CASE AND REVIEW OF THE LITERATURE

被引:28
作者
TAKEUCHI, A
YOSHIZAWA, N
OSHIMA, S
KUBOTA, T
OSHIKAWA, Y
AKASHI, Y
ODA, T
NIWA, H
IMAZEKI, N
SENO, A
FUSE, Y
机构
[1] NATL DEF MED COLL,DEPT MED,3-2 NAMIKI,TOKOROZAWA,SAITAMA 359,JAPAN
[2] NATL DEF MED COLL,DEPT PATHOL,TOKOROZAWA,SAITAMA 359,JAPAN
来源
NEPHRON | 1992年 / 60卷 / 04期
关键词
GERMANIUM; NEPHROTOXICITY;
D O I
10.1159/000186805
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 55-year-old woman was admitted to our hospital, complaining of general malaise, muscular weakness, anorexia and weight loss. She had a history of ingesting of a certain germanium (Ge) compound over the preceding 19 months, with a total dose of 47 g as Ge element. She was found to have renal failure (blood urea nitrogen, 44 mg/dl; serum creatinine, 2.6 mg/dl) without abnormal findings in urinalysis, and muscular and nervous damage. Initially, polymyositis was diagnosed and prednisolone administered. However, no improvement was seen. and neuromuscular symptoms and signs steadily worsened, ending in death. Microscopic study of the kidney showed that lipofuscin granules increased in the cells of the thick ascending limb of Henle's loop to the distal convoluted tubule accompanying mild tubular atrophy and that some of the tubules of these segments had vacuolar degeneration or desquamation. No apparent glomerular and vascular changes were observed. High Ge content was found in serum, urine and various tissues, e.g., spleen, liver, kidney, adrenal gland and myocardium. while in controls Ge could not be detected in sera, urine or tissues. We also review case reports about Ge toxicity, and discuss the pathogenesis of renal failure induced by Ge compounds.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 21 条
  • [1] ABRAHAMS C, 1964, ARCH PATHOL, V78, P222
  • [2] DEXEUS FH, 1986, CANCER TREAT REP, V70, P1120
  • [3] GADIALLY FN, 1988, ULTRASTRUCT PATHOL, V2, P608
  • [4] KOBAYASHI K, 1989, Japanese Journal of Clinical Electron Microscopy, V22, P1
  • [5] KUEBLER JP, 1984, CANCER TREAT REP, V68, P1515
  • [6] MATSUSAKA T, 1988, CLIN NEPHROL, V30, P341
  • [7] NAGATA N, 1985, Journal of Toxicological Sciences, V10, P333
  • [8] NAKANO T, 1987, J CLIN ELECT MICROSC, V20, P5
  • [9] Obara K, 1988, Nihon Naika Gakkai Zasshi, V77, P1704
  • [10] OKAGAWA K, 1986, NAIKA, V58, P1210